Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 664 entries
Sorted by: Best Match Show Resources per page
Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children.

Pediatric gastroenterology, hepatology & nutrition

Hong J, Yang HR.
PMID: 24010093
Pediatr Gastroenterol Hepatol Nutr. 2012 Dec;15(4):237-42. doi: 10.5223/pghn.2012.15.4.237. Epub 2012 Dec 31.

PURPOSE: The aim of this study was to assess and compare the efficacies of proton pump inhibitor-based triple therapy and bismuth-based quadruple therapy as first-line treatments for Helicobacter pylori eradication in Korean children.METHODS: We retrospectively reviewed the data of...

Cite
Hong J, Yang HR. Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children. Pediatr Gastroenterol Hepatol Nutr. 2012;15(4):237-42doi: 10.5223/pghn.2012.15.4.237.
Hong, J., & Yang, H. R. (2012). Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children. Pediatric gastroenterology, hepatology & nutrition, 15(4), 237-42. https://doi.org/10.5223/pghn.2012.15.4.237
Hong, Jeana, and Yang, Hye Ran. "Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children." Pediatric gastroenterology, hepatology & nutrition vol. 15,4 (2012): 237-42. doi: https://doi.org/10.5223/pghn.2012.15.4.237
Hong J, Yang HR. Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children. Pediatr Gastroenterol Hepatol Nutr. 2012 Dec;15(4):237-42. doi: 10.5223/pghn.2012.15.4.237. Epub 2012 Dec 31. PMID: 24010093; PMCID: PMC3746056.
Copy Download .nbib Format: NLM
Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey.

The Libyan journal of medicine

Alkim H, Iscan M, Oz F.
PMID: 21912572
Libyan J Med. 2011;6. doi: 10.3402/ljm.v6i0.8412. Epub 2011 Sep 08.

BACKGROUND: Helicobacter pylori infection is the main cause of gastritis, gastroduodenal ulcer disease, MALT lymphoma, and adenocarcinoma of the stomach. The reported prevalence of H. pylori in the adult population in Turkey is 67.6%-81.3%. A national meta-analysis showed that...

Cite
Alkim H, Iscan M, Oz F. Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey. Libyan J Med. 2011;6doi: 10.3402/ljm.v6i0.8412.
Alkim, H., Iscan, M., & Oz, F. (2011). Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey. The Libyan journal of medicine, 6. https://doi.org/10.3402/ljm.v6i0.8412
Alkim, Huseyin, et al. "Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey." The Libyan journal of medicine vol. 6 (2011). doi: https://doi.org/10.3402/ljm.v6i0.8412
Alkim H, Iscan M, Oz F. Effectiveness of ranitidine bismuth citrate and proton pump inhibitor based triple therapies of Helicobacter pylori in Turkey. Libyan J Med. 2011;6. doi: 10.3402/ljm.v6i0.8412. Epub 2011 Sep 08. PMID: 21912572; PMCID: PMC3171195.
Copy Download .nbib Format: NLM
Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.

Therapeutic advances in gastroenterology

Katz P, Kahrilas PJ, Johnson DA, Lind T, Röhss K, Traxler B, Hugo V, Dent J.
PMID: 26557888
Therap Adv Gastroenterol. 2015 Nov;8(6):322-30. doi: 10.1177/1756283X15592583.

OBJECTIVES: In mild gastroesophageal reflux disease, which accounts for the great majority of cases, the major burden of reflux occurs during daytime hours, after food intake. The aim of these analyses was to evaluate intragastric pH control during the...

Cite
Katz P, Kahrilas PJ, Johnson DA, et al. Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors. Therap Adv Gastroenterol. 2015;8(6):322-30doi: 10.1177/1756283X15592583.
Katz, P., Kahrilas, P. J., Johnson, D. A., Lind, T., Röhss, K., Traxler, B., Hugo, V., & Dent, J. (2015). Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors. Therapeutic advances in gastroenterology, 8(6), 322-30. https://doi.org/10.1177/1756283X15592583
Katz, Philip, et al. "Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors." Therapeutic advances in gastroenterology vol. 8,6 (2015): 322-30. doi: https://doi.org/10.1177/1756283X15592583
Katz P, Kahrilas PJ, Johnson DA, Lind T, Röhss K, Traxler B, Hugo V, Dent J. Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors. Therap Adv Gastroenterol. 2015 Nov;8(6):322-30. doi: 10.1177/1756283X15592583. PMID: 26557888; PMCID: PMC4622284.
Copy Download .nbib Format: NLM
Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Wang W, Seeruttun SR, Fang C, Zhou Z.
PMID: 25232226
Chin J Cancer Res. 2014 Aug;26(4):501-6. doi: 10.3978/j.issn.1000-9604.2014.08.16.

A 64-year-old man was admitted to the Sun Yat-Sen University Cancer Center with chief complaints of recurrent abdominal pain and diarrhea for about 3 years and with a history of surgical repair for intestinal perforation owing to stress ulcer....

Cite
Wang W, Seeruttun SR, Fang C, et al. Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases. Chin J Cancer Res. 2014;26(4):501-6doi: 10.3978/j.issn.1000-9604.2014.08.16.
Wang, W., Seeruttun, S. R., Fang, C., & Zhou, Z. (2014). Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 26(4), 501-6. https://doi.org/10.3978/j.issn.1000-9604.2014.08.16
Wang, Wei, et al. "Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases." Chinese journal of cancer research = Chung-kuo yen cheng yen chiu vol. 26,4 (2014): 501-6. doi: https://doi.org/10.3978/j.issn.1000-9604.2014.08.16
Wang W, Seeruttun SR, Fang C, Zhou Z. Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases. Chin J Cancer Res. 2014 Aug;26(4):501-6. doi: 10.3978/j.issn.1000-9604.2014.08.16. PMID: 25232226; PMCID: PMC4153935.
Copy Download .nbib Format: NLM
Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran.

Przeglad gastroenterologiczny

Masjedizadeh A, Zaeemzadeh N, Mard SA, Vanani GS.
PMID: 26557940
Prz Gastroenterol. 2015;10(2):94-9. doi: 10.5114/pg.2015.49001. Epub 2015 Feb 10.

INTRODUCTION: Helicobacter pylori (H. pylori) is the common cause of many gastrointestinal diseases, especially peptic ulcer. Therefore, a successful treatment of this infection decreases the financial burden on health systems.AIM: Different combinations of antibiotics are used for the eradication...

Cite
Masjedizadeh A, Zaeemzadeh N, Mard SA, et al. Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran. Prz Gastroenterol. 2015;10(2):94-9doi: 10.5114/pg.2015.49001.
Masjedizadeh, A., Zaeemzadeh, N., Mard, S. A., & Vanani, G. S. (2015). Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran. Przeglad gastroenterologiczny, 10(2), 94-9. https://doi.org/10.5114/pg.2015.49001
Masjedizadeh, Abdolrahim, et al. "Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran." Przeglad gastroenterologiczny vol. 10,2 (2015): 94-9. doi: https://doi.org/10.5114/pg.2015.49001
Masjedizadeh A, Zaeemzadeh N, Mard SA, Vanani GS. Comparing the efficacy of four different protocols for eradicating of Helicobacter pylori infection in Ahvaz, southwest Iran. Prz Gastroenterol. 2015;10(2):94-9. doi: 10.5114/pg.2015.49001. Epub 2015 Feb 10. PMID: 26557940; PMCID: PMC4631277.
Copy Download .nbib Format: NLM
Effect of Radix Sophorae Tonkinensis on the activity of cytochrome P450 isoforms in rats.

International journal of clinical and experimental medicine

Cai J, Ma J, Xu K, Gao G, Xiang Y, Lin C.
PMID: 26309650
Int J Clin Exp Med. 2015 Jun 15;8(6):9737-43. eCollection 2015.

Radix Sophorae Tonkinensis (S. tonkinensis) is the processed lateral root of Sophora subprostrata (Leguminosae) that widely distributed over the southwest China. Radix Sophorae Tonkinensis has been widely used as a Chinese medicinal herb for the treatment of disease such...

Cite
Cai J, Ma J, Xu K, et al. Effect of Radix Sophorae Tonkinensis on the activity of cytochrome P450 isoforms in rats. Int J Clin Exp Med. 2015;8(6):9737-43
Cai, J., Ma, J., Xu, K., Gao, G., Xiang, Y., & Lin, C. (2015). Effect of Radix Sophorae Tonkinensis on the activity of cytochrome P450 isoforms in rats. International journal of clinical and experimental medicine, 8(6), 9737-43.
Cai, Jinzhang, et al. "Effect of Radix Sophorae Tonkinensis on the activity of cytochrome P450 isoforms in rats." International journal of clinical and experimental medicine vol. 8,6 (2015): 9737-43.
Cai J, Ma J, Xu K, Gao G, Xiang Y, Lin C. Effect of Radix Sophorae Tonkinensis on the activity of cytochrome P450 isoforms in rats. Int J Clin Exp Med. 2015 Jun 15;8(6):9737-43. eCollection 2015. PMID: 26309650; PMCID: PMC4538074.
Copy Download .nbib Format: NLM
Effects of clarithromycin, omeprazole and leminoprazole on gastric ulcer healing in Helicobacter pylori-infected rats.

Journal of gastroenterology and hepatology

Li T, Okabe S.
PMID: 28976660
J Gastroenterol Hepatol. 1998 Nov;13:S185-S189. doi: 10.1111/j.1440-1746.1998.tb01874.x.

We examined whether a single inoculation of Helicobacter pylori can colonize the stomachs of ulcerated rats and delay their healing and whether an antibiotic drug and acid pump inhibitors can enhance the ulcer healing in infected rats. Ulcers were...

Cite
Li T, Okabe S. Effects of clarithromycin, omeprazole and leminoprazole on gastric ulcer healing in Helicobacter pylori-infected rats. J Gastroenterol Hepatol. 1998;13:S185-S189doi: 10.1111/j.1440-1746.1998.tb01874.x.
Li, T., & Okabe, S. (1998). Effects of clarithromycin, omeprazole and leminoprazole on gastric ulcer healing in Helicobacter pylori-infected rats. Journal of gastroenterology and hepatology, 13S185-S189. https://doi.org/10.1111/j.1440-1746.1998.tb01874.x
Li, T, and Okabe, S. "Effects of clarithromycin, omeprazole and leminoprazole on gastric ulcer healing in Helicobacter pylori-infected rats." Journal of gastroenterology and hepatology vol. 13 (1998): S185-S189. doi: https://doi.org/10.1111/j.1440-1746.1998.tb01874.x
Li T, Okabe S. Effects of clarithromycin, omeprazole and leminoprazole on gastric ulcer healing in Helicobacter pylori-infected rats. J Gastroenterol Hepatol. 1998 Nov;13:S185-S189. doi: 10.1111/j.1440-1746.1998.tb01874.x. PMID: 28976660.
Copy Download .nbib Format: NLM
Toxic epidermal necrolysis in polymedicated patient treated with radiotherapy.

Allergy, asthma & immunology research

Pérez-Calderón R, Gonzalo-Garijo MA, Corrales-Vargas S, Jiménez-Ferrera G, Rodríguez-Nevado I, Díaz-Delgado M.
PMID: 25729629
Allergy Asthma Immunol Res. 2015 Mar;7(2):199-201. doi: 10.4168/aair.2015.7.2.199. Epub 2014 Sep 19.

Temozolomide is an oral alkylating agent indicated for the treatment of patients with glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment. We report the case of a patient who developed toxic epidermal necrolysis (TEN) while she was...

Cite
Pérez-Calderón R, Gonzalo-Garijo MA, Corrales-Vargas S, et al. Toxic epidermal necrolysis in polymedicated patient treated with radiotherapy. Allergy Asthma Immunol Res. 2014;7(2):199-201doi: 10.4168/aair.2015.7.2.199.
Pérez-Calderón, R., Gonzalo-Garijo, M. A., Corrales-Vargas, S., Jiménez-Ferrera, G., Rodríguez-Nevado, I., & Díaz-Delgado, M. (2015). Toxic epidermal necrolysis in polymedicated patient treated with radiotherapy. Allergy, asthma & immunology research, 7(2), 199-201. https://doi.org/10.4168/aair.2015.7.2.199
Pérez-Calderón, Remedios, et al. "Toxic epidermal necrolysis in polymedicated patient treated with radiotherapy." Allergy, asthma & immunology research vol. 7,2 (2015): 199-201. doi: https://doi.org/10.4168/aair.2015.7.2.199
Pérez-Calderón R, Gonzalo-Garijo MA, Corrales-Vargas S, Jiménez-Ferrera G, Rodríguez-Nevado I, Díaz-Delgado M. Toxic epidermal necrolysis in polymedicated patient treated with radiotherapy. Allergy Asthma Immunol Res. 2015 Mar;7(2):199-201. doi: 10.4168/aair.2015.7.2.199. Epub 2014 Sep 19. PMID: 25729629; PMCID: PMC4341343.
Copy Download .nbib Format: NLM
Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes.

Hepatology research : the official journal of the Japan Society of Hepatology

Higuchi Y, Kawai K, Kanaki T, Yamazaki H, Chesné C, Guguen-Guillouzo C, Suemizu H.
PMID: 26724677
Hepatol Res. 2016 Sep;46(10):1045-57. doi: 10.1111/hepr.12644. Epub 2016 Feb 07.

AIM: The hepatoma-derived cell line HepaRG is regarded as an in vitro model of drug metabolism because fully differentiated HepaRG cells demonstrate functional metabolic responses comparable to those of primary human hepatocytes. Recently, it was demonstrated that the 3D...

Cite
Higuchi Y, Kawai K, Kanaki T, et al. Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatol Res. 2016;46(10):1045-57doi: 10.1111/hepr.12644.
Higuchi, Y., Kawai, K., Kanaki, T., Yamazaki, H., Chesné, C., Guguen-Guillouzo, C., & Suemizu, H. (2016). Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatology research : the official journal of the Japan Society of Hepatology, 46(10), 1045-57. https://doi.org/10.1111/hepr.12644
Higuchi, Yichiro, et al. "Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,10 (2016): 1045-57. doi: https://doi.org/10.1111/hepr.12644
Higuchi Y, Kawai K, Kanaki T, Yamazaki H, Chesné C, Guguen-Guillouzo C, Suemizu H. Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatol Res. 2016 Sep;46(10):1045-57. doi: 10.1111/hepr.12644. Epub 2016 Feb 07. PMID: 26724677.
Copy Download .nbib Format: NLM
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy.

Therapeutics and clinical risk management

Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q.
PMID: 25848291
Ther Clin Risk Manag. 2015 Mar 19;11:449-67. doi: 10.2147/TCRM.S80437. eCollection 2015.

BACKGROUND: Coprescribing of clopidogrel and other drugs is common. Available reviews have addressed the drug-drug interactions (DDIs) when clopidogrel is as an object drug, or focused on combination use of clopidogrel and a special class of drugs. Clinicians may...

Cite
Wang ZY, Chen M, Zhu LL, et al. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag. 2015;11:449-67doi: 10.2147/TCRM.S80437.
Wang, Z. Y., Chen, M., Zhu, L. L., Yu, L. S., Zeng, S., Xiang, M. X., & Zhou, Q. (2015). Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Therapeutics and clinical risk management, 11449-67. https://doi.org/10.2147/TCRM.S80437
Wang, Zhi-Yu, et al. "Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy." Therapeutics and clinical risk management vol. 11 (2015): 449-67. doi: https://doi.org/10.2147/TCRM.S80437
Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag. 2015 Mar 19;11:449-67. doi: 10.2147/TCRM.S80437. eCollection 2015. PMID: 25848291; PMCID: PMC4373598.
Copy Download .nbib Format: NLM
Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication.

Asian Pacific journal of cancer prevention : APJCP

Chunlertlith K, Limpapanasit U, Mairiang P, Vannaprasaht S, Tassaneeyakul W, Sangchan A, Sawadpanich K, Suttichaimongkol T, Pongpit J, Pattarapongsin M.
PMID: 28545189
Asian Pac J Cancer Prev. 2017 Apr 01;18(4):927-932. doi: 10.22034/APJCP.2017.18.4.927.

Background: Helicobacter pylori (H. pylori) infection is related to peptic ulcer diseases and gastric cancer and eradication of H. pylori should be expected to decrease the risk of their development. Factors affecting H. pylori eradication are antibiotic resistance, CYP2C19...

Cite
Chunlertlith K, Limpapanasit U, Mairiang P, et al. Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication. Asian Pac J Cancer Prev. 2017;18(4):927-932doi: 10.22034/APJCP.2017.18.4.927.
Chunlertlith, K., Limpapanasit, U., Mairiang, P., Vannaprasaht, S., Tassaneeyakul, W., Sangchan, A., Sawadpanich, K., Suttichaimongkol, T., Pongpit, J., & Pattarapongsin, M. (2017). Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication. Asian Pacific journal of cancer prevention : APJCP, 18(4), 927-932. https://doi.org/10.22034/APJCP.2017.18.4.927
Chunlertlith, Kitti, et al. "Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication." Asian Pacific journal of cancer prevention : APJCP vol. 18,4 (2017): 927-932. doi: https://doi.org/10.22034/APJCP.2017.18.4.927
Chunlertlith K, Limpapanasit U, Mairiang P, Vannaprasaht S, Tassaneeyakul W, Sangchan A, Sawadpanich K, Suttichaimongkol T, Pongpit J, Pattarapongsin M. Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication. Asian Pac J Cancer Prev. 2017 Apr 01;18(4):927-932. doi: 10.22034/APJCP.2017.18.4.927. PMID: 28545189; PMCID: PMC5494241.
Copy Download .nbib Format: NLM
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?.

Clinical and translational gastroenterology

Hunt RH, Scarpignato C.
PMID: 26513137
Clin Transl Gastroenterol. 2015 Oct 29;6:e119. doi: 10.1038/ctg.2015.39.

The need for new acid suppressing agents with improved pharmacology and superior antisecretory effects to address unmet clinical needs in acid-related disorders has been evident for over a decade. Recent new antisecretory drugs (IR-omeprazole and MR-dexlansoprazole) only provide a...

Cite
Hunt RH, Scarpignato C. Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?. Clin Transl Gastroenterol. 2015;6:e119doi: 10.1038/ctg.2015.39.
Hunt, R. H., & Scarpignato, C. (2015). Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?. Clinical and translational gastroenterology, 6e119. https://doi.org/10.1038/ctg.2015.39
Hunt, Richard H, and Scarpignato, Carmelo. "Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?." Clinical and translational gastroenterology vol. 6 (2015): e119. doi: https://doi.org/10.1038/ctg.2015.39
Hunt RH, Scarpignato C. Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?. Clin Transl Gastroenterol. 2015 Oct 29;6:e119. doi: 10.1038/ctg.2015.39. PMID: 26513137; PMCID: PMC4816037.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 664 entries